Company Filing History:
Years Active: 2025
Title: Innovations of Virangika K Wimalasena
Introduction
Virangika K Wimalasena is an accomplished inventor based in Brookline, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of small molecule compounds that target specific proteins for therapeutic purposes. His work is pivotal in advancing treatment options for various diseases.
Latest Patents
Wimalasena holds a patent for a groundbreaking invention titled "Small molecule target bromo/acetyl proteins and uses thereof." This patent discloses bispecific compounds, known as degraders, that specifically target EP300/CBP for degradation. The patent also includes pharmaceutical compositions containing these degraders and outlines methods for using the compounds to treat diseases. He has 1 patent to his name.
Career Highlights
Virangika K Wimalasena is currently associated with the Dana-Farber Cancer Institute Inc., where he continues to innovate and contribute to cancer research. His expertise in small molecule development has positioned him as a key figure in the fight against cancer.
Collaborations
Wimalasena has collaborated with notable colleagues, including Jun Qi and Deyao Li. These partnerships enhance the research efforts at the Dana-Farber Cancer Institute and contribute to the advancement of cancer therapies.
Conclusion
Virangika K Wimalasena's work exemplifies the intersection of innovation and healthcare. His contributions to the development of targeted therapies are crucial in the ongoing battle against cancer.